Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".
Autors principals: | Mavaddat, N, Roalfe, A, Fletcher, K, Lip, G, Hobbs, R, Fitzmaurice, D, Mant, J |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2014
|
Ítems similars
-
Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
per: Mavaddat, N, et al.
Publicat: (2014) -
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
per: Mant, J, et al.
Publicat: (2007) -
Warfarin versus aspirin for prevention of cognitive decline in an elderly community population with atrial fibrillation (the BAFTA Study): a randomised controlled trial
per: Mavaddat, N, et al.
Publicat: (2013) -
Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.
per: Jowett, S, et al.
Publicat: (2011) -
Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?
per: Mant, J, et al.
Publicat: (2008)